GlassScriptPhysician profile
Mitchell F Weiss
NPI 1982643458
$549.34
in general payments reported to CMS, 2019-2025
13 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $25.91 · 2022: $199 · 2023: $90.07 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $103.90 | 2020-2022 | |
| Teleflex LLC | $86.74 | 2025 | Barrigel |
| Palette Life Sciences, INC. | $72.55 | 2022-2023 | |
| Sumitomo Pharma America, INC. | $49.77 | 2023 | Orgovyx |
| Novocure INC. | $45.76 | 2019 | |
| Siemens Medical Solutions USA, INC. | $40.40 | 2022 | |
| Mevion_medical_systems_inc | $33.53 | 2022 | |
| Varian Medical Systems, INC. | $33.52 | 2019 | |
| Bioprotect Medical, INC. | $26.53 | 2025 | Bioprotect Balloon Implant System |
| Bayer Healthcare Pharmaceuticals INC. | $18.50 | 2019 | |
| Myriad Genetic Laboratories, INC. | $14.55 | 2023 | Prolaris |
| Celgene Corporation | $12.27 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.